EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Decoding IGLL5 Mutation‐Mediated BCR Signaling: A Novel Mechanism of CD8 + T Cell Exhaustion and Ocular MALT Lymphoma Progression

Andi Zhao, Haoyu Wei, Chenyu Zhou, Xinping Sun, Shuyan Da, Haiyu Liu, Zijin Wang, Hui Zhu, Shiya Shen, Qing Shao, Qi Gong, Hu Liu und 1 weitere

Advanced Science · 2026-08 · 13 (44)

DOI: 10.1002/advs.202518780 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 12.05.2026. Verfasst von Andi Zhao und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Lymphoma, B-Cell, Marginal Zone, Eye Neoplasms, Receptors, Antigen, B-Cell. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Jiangsu Province's Science and Technology Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ocular adnexal mucosa‐associated lymphoid tissue lymphoma (OAML) is driven by both genetic and immune microenvironmental factors, yet its pathogenic mechanisms remain incompletely understood. We previously identified IGLL5 as a recurrently mutated gene associated with poor prognosis in OAML. Functional and mechanistic analyses focusing on the S47G and A54G mutants show that these variants enhance association with the CD79A/CD79B complex, leading to persistent B‐cell receptor (BCR) signaling. This signaling is accompanied by upregulation of CXCL10 and CXCL11, increased CD8 + T cell recruitment, and an exhaustion‐associated dysfunctional phenotype that may contribute to an immune‐tolerant microenvironment. Pharmacologic inhibition further shows that combined BTK inhibitor and rituximab treatment suppresses IGLL5‐associated BCR activation. Together, these findings support a mutation‐associated mechanism in a subset of OAML and nominate IGLL5‐related signaling as a potential therapeutic vulnerability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CD8-Positive T-LymphocytesLymphoma, B-Cell, Marginal ZoneEye NeoplasmsReceptors, Antigen, B-CellHumansT-Cell ExhaustionSignal TransductionMutationDisease Progression

Stichwörter der Autor:innen

B‐cell receptor (BCR) signalingIGLL5 mutationsOAML (ocular adnexal MALT lymphoma)T‐cell exhaustion

Substanzen

Receptors, Antigen, B-Cell

Autor:innen und Institutionen

  • Department of Ophthalmology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
  • Nanjing Medical University, Nanjing, China.

ORCID-Profile: Xuejuan Chen

Förderung

  • National Natural Science Foundation of China
  • Jiangsu Province's Science and Technology Project

Zitieren

APA

Zhao, A., Wei, H., Zhou, C., Sun, X., Da, S., Liu, H., Wang, Z., Zhu, H., Shen, S., Shao, Q., Gong, Q., Liu, H., & Chen, X. (2026). Decoding IGLL5 Mutation‐Mediated BCR Signaling: A Novel Mechanism of CD8 + T Cell Exhaustion and Ocular MALT Lymphoma Progression. Advanced Science, 13(44). https://doi.org/10.1002/advs.202518780

Vancouver

Zhao A, Wei H, Zhou C, Sun X, Da S, Liu H, et al. Decoding IGLL5 Mutation‐Mediated BCR Signaling: A Novel Mechanism of CD8 + T Cell Exhaustion and Ocular MALT Lymphoma Progression. Advanced Science. 2026;13(44). doi:10.1002/advs.202518780

BibTeX
@article{Zhao2026,
  author = {Zhao, Andi and Wei, Haoyu and Zhou, Chenyu and Sun, Xinping and Da, Shuyan and Liu, Haiyu and Wang, Zijin and Zhu, Hui and Shen, Shiya and Shao, Qing and Gong, Qi and Liu, Hu and Chen, Xuejuan},
  title = {Decoding IGLL5 Mutation‐Mediated BCR Signaling: A Novel Mechanism of CD8 + T Cell Exhaustion and Ocular MALT Lymphoma Progression},
  journal = {Advanced Science},
  year = {2026},
  volume = {13},
  number = {44},
  doi = {10.1002/advs.202518780}
}
Kostenlos starten →